Journal of Korean Society for Clinical Pharmacology and Therapeutics (임상약리학회지)

Korean Society for Clinical Pharmacology and Therapeutics (대한임상약리학회)
권호 표지

Guidance for the Clinical Trials Evaluation for Hypertension

고혈압치료제의 임상시험평가지침 연구

  • Park, Hyun-Joo (Clinical Research Division, Toxicological Evaluation and Research Department, National Institute Food and Drug Safety Evaluation) ;
  • Oh, Woo-Yong (Oncology and Antibiotics Division, Korea Food and Drug Administration) ;
  • Na, Han-Sung (Clinical Research Division, Toxicological Evaluation and Research Department, National Institute Food and Drug Safety Evaluation) ;
  • Han, Soon-Young (Clinical Research Division, Toxicological Evaluation and Research Department, National Institute Food and Drug Safety Evaluation) ;
  • Choi, Ki-Hwan (Cardiovascular and Neuropharmacology Drug Division, Korea Food and Drug Administration) ;
  • Ko, Yong-Suk (Cardiovascular and Neuropharmacology Drug Division, Korea Food and Drug Administration) ;
  • Wang, So-Young (Cardiovascular and Neuropharmacology Drug Division, Korea Food and Drug Administration) ;
  • Chung, Myeon-Woo (Clinical Research Division, Toxicological Evaluation and Research Department, National Institute Food and Drug Safety Evaluation)
  • 박현주 (식품의약품안전평가원 임상연구과) ;
  • 오우용 (식품의약품안전청 종양약품과) ;
  • 나한성 (식품의약품안전평가원 임상연구과) ;
  • 한순영 (식품의약품안전평가원 임상연구과) ;
  • 최기환 (식품의약품안전청 순환계약품과) ;
  • 고용석 (식품의약품안전청 순환계약품과) ;
  • 왕소영 (식품의약품안전청 순환계약품과) ;
  • 정면우 (식품의약품안전평가원 임상연구과)
  • Received : 2009.10.14
  • Accepted : 2009.12.17
  • Published : 2009.12.30

⟨ Previous Next ⟩

Abstract

Keywords

References

  1. Principles for Clinical Evaluation of New Antihypertensive Drugs. FDA 2000. Available from : http://www.fda.gov/downloads/Drugs/GuidanceComplianceRegulatoryInformation/Guidances/ucm073147.pdf
  2. Note for Guidance on Clinical Investigation of Medicinal Products in the Treatment of Hypertension. EMEA 2004. Available from: http://www.emea.europa.eu/pdfs/human/ewp/023895en.pdf
  3. Concept Paper on the Need for Regulatory Guidance in the Evaluation of Medicinal Products for a First-Line Indication of Fixed Combination Medicinal Products in Therapeutic Doses in the Treatment of Hypertension. EMEA 2006. Available from: http://www.emea.europa.eu/pdfs/human/ewp/42609306en.pdf
  4. Chobanian AV, et al. Seventh report of the Joint National Committee on Prevention, Detection, and Treatment of High Blood Pressure. Hypertension 2003;42:1206-52. https://doi.org/10.1161/01.HYP.0000107251.49515.c2
  5. Guideline Committee. 2007 European Society of Hypertension-European Society of cardiology guideline for the management of arterial hypertension (Journal of hypertension 2007, 25:1751-1762) https://doi.org/10.1097/HJH.0b013e3282f0580f
  6. Guidelines Sub-Committee. 1999 World Health Organization-International Society of Hypertension guidelines for the management of hypertension. J Hypertens 1999;17:151-83.
  7. PA Meredith. Importance of trough : peak ratios in treatment of blood pressure in postmyocardial infarction and heart failure settings. J Human Hypertens 1997;11:39–43 https://doi.org/10.1038/sj.jhh.1000399
  8. 우리나라의 고혈압 진료지침 (대한고혈압학회, 2004년)
  9. 혈압 모니터 지침 (대한고혈압학회, 2007년)
  10. Guideline on the evaluation of medical products for cardiovascular disease prevention (EMEA guideline, 2007)
  11. 고혈압치료제의 임상시험평가지침 (식품의약품안전청, 2009)